NDC 63552-722-10
FLUZONE HIGH DOSE NORTHERN HEMISPHERE 60 ug/.5mL
influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) · INJECTION, SUSPENSION
FLUZONE HIGH DOSE NORTHERN HEMISPHERE is a injection, suspension containing influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) at a strength of 60 ug/.5mL. Manufactured by Patheon Manufacturing Services LLC.
Key Facts
- Brand Name
- FLUZONE HIGH DOSE NORTHERN HEMISPHERE
- Generic Name
- influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)
- NDC Code (Package)
63552-722-10- NDC Code (Product)
63552-722- Manufacturer
- Patheon Manufacturing Services LLC
- Strength
- 60 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103914
- Marketing Start
- 09/01/2025
Recall History
No Recall HistoryView Full Drug Page
FLUZONE HIGH DOSE NORTHERN HEMISPHERE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.